MG53 levels were elevated in patients with stable CHD andthose with comorbidities such as CKD and DM, and highest in those with AMI.Furthermore, the severity of CVD and AMI correlated with MG53 levels afteradjustment for multiple risk factors and clinical biomarkers [73]. The gene discussed is TRIM72; the disease is coronary artery disorder.